As a result, the objective of this study was to examine the clinical characteristics of patients with macular edema secondary to retinal vein occlusion (RVO) who had an inadequate response to treatment and still had remaining fluid visible on OCT images after three consecutive loading doses of anti-VEGF. This evidence concerns the gene VEGFA and macular retinal edema.